Silo Pharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Silo Pharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Silo Pharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $2.54M, a 63.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.54M +$988K +63.7% Dec 31, 2023 10-K 2024-03-25
Q4 2022 $1.55M +$941K +154% Dec 31, 2022 10-K 2024-03-25
Q4 2021 $610K -$383K -38.6% Dec 31, 2021 10-K 2023-03-24
Q4 2020 $992K +$378K +61.4% Dec 31, 2020 10-K/A 2021-05-17
Q4 2019 $615K +$116K +23.3% Dec 31, 2019 10-K/A 2021-05-17
Q4 2018 $498K +$190K +61.6% Dec 31, 2018 10-K 2020-03-20
Q4 2017 $309K Dec 31, 2017 10-K 2019-04-04
Q4 2013 -$22K +$14K +38.9% Dec 31, 2013 10-K 2014-03-31
Q4 2012 -$36K -$57K -271% Dec 31, 2012 10-K 2014-03-31
Q4 2011 $21K Dec 31, 2011 10-K 2013-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.